Depressive Symptoms and Quality of Life in Patients with Type 2 Diabetes Mellitus

碩士 === 美和技術學院 === 健康照護研究所 === 93 === Diabetes mellitus (DM) affected patients not only physical but also psychosocial and quality of life. The purpose of this study was to explore the relationship among the demographic characteristics, illness status, depressive symptoms and the quality of life in p...

Full description

Bibliographic Details
Main Authors: Hsiu-feng Chen, 陳秀鳳
Other Authors: None
Format: Others
Language:zh-TW
Published: 2005
Online Access:http://ndltd.ncl.edu.tw/handle/56166218946147298848
Description
Summary:碩士 === 美和技術學院 === 健康照護研究所 === 93 === Diabetes mellitus (DM) affected patients not only physical but also psychosocial and quality of life. The purpose of this study was to explore the relationship among the demographic characteristics, illness status, depressive symptoms and the quality of life in patients with type 2 diabetes mellitus. The study was a descriptive, correlative design. Purposive sampling was used to collect data from 151 patients in adults with type 2 diabetes mellitus. Participants were recruited from three outpatient canters in Pingtung. The research instruments included the demographic characteristics, the Center for Epidemiologic Studies-Depression (CES-D), and the World Health Organization Quality of Life-BREF (WHOQOL - BREF). The statistical methods included descriptive analysis, independent t-test, Pearson,s product moment correlation and multiple regression analysis. Results indicated female DM patients had more depressive symptoms than DM males. DM patients with higher blood glucose level and higher glycosylated haemoglobin (HbA1c) had more depressive symptoms than those with lower blood glucose and HbA1c. Participants had longer duration of diabetes, higher blood glucose level, and HbA1c level had worse quality of life than others. Different gender, education level, and economic status of DM patients had different quality of life. Healthcare professionals may use these results to provide healthcare and enhance the quality of life of type 2 DM patients.